Stockreport

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced promising preclinical imaging and therapeutic efficacy data fo [Read more]